Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Vaccines
Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects
Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.
Drug Discovery & Development
The Challenges Facing Antibody-Drug Conjugates for Immuno-Oncology
The targeted cancer therapy has made recent clinical and market breakthroughs, but what are the next hurdles for ADCs?
Vaccines
Advanced Vaccine Platforms & Technologies
Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.
Vaccines
Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study
Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.
Drug Discovery & Development
Immuno Oncology Investigations: The NKG2D Pathway, Diagnostic Biomarker, and Allogenic CAR Ts
Cell UK 2021 hosts experts in cell and immunotherapy working towards new diagnostic tools and therapies.